🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Courtney R. Schott

University of Guelph

ORCID: 0000-0003-2147-6297
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach”.

Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0873
N/A
0DataRank · unranked
36 citations

Amanda Koehne, Leanne C. Sayles, Elizabeth P. Young, Cuyler Luck, Katharine Yu +22 more

Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.19.524562
N/A
0DataRank · unranked
4 citations

Amanda Koehne, Leanne C. Sayles, Elizabeth P. Young, Cuyler Luck, Katharine Yu +22 more

Data from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

(2024)10.1158/1078-0432.c.7077821.v1
N/A
0DataRank · unranked
0 citations

Amanda Koehne, Leanne C. Sayles, Elizabeth P. Young, Cuyler Luck, Katharine Yu +22 more

Data from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

(2024)10.1158/1078-0432.c.7077821
N/A
0DataRank · unranked
0 citations

Amanda Koehne, Leanne C. Sayles, Elizabeth P. Young, Cuyler Luck, Katharine Yu +22 more